Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
Holding DOCS?
Track your performance easily
DOCS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$22.96 - $61.75
Previous CloseN/A
Volume296.07K
Average Volume (3M)1.87M
Market Cap
$9.93B
Enterprise Value$7.94B
Total Cash (Recent Filing)$86.45M
Total Debt (Recent Filing)$324.00K
Price to Earnings (P/E)61.2
Beta1.97
Next Earnings
Feb 06, 2025EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.87
Shares Outstanding128,135,990
10 Day Avg. Volume1,480,929
30 Day Avg. Volume1,870,544
Standard Deviation0.17
R-Squared0.15
Alpha0.00023
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)19.13
Price to Cash Flow (P/CF)36.20
P/FCF Ratio37.00
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue15.36
Enterprise Value/Gross Profit18.69
Enterprise Value/Ebitda34.27
Forecast
1Y Price Target
$58.14Price Target Upside9.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Doximity News
Bulls Say, Bears Say
Bulls Say
Market Position And GrowthDoximity's revenue is expected to grow 14% in CY24, well above the expected 7% growth for digital ad spending in the HCP market.
Revenue Growth PotentialDoximity generates digital ad revenue from only ~50-55% of all pharmaceutical brands that are currently generating >$100M in annual U.S. product sales, giving Doximity a long runway for additional revenue opportunity.
User Engagement And PartnershipsHeavy user engagement on the app has allowed Doximity to attract ~100+ biopharma companies to spend at least $500k annually on digital pharma marketing spend.
Bears Say
Growth ChallengesThe implied 4Q guidance suggests a notable decline in revenue growth and adjusted EBITDA margin, raising concerns about the sustainability of current growth rates.
Marketing SpendPotential slowdown in marketing spend among biopharma companies toward prescribing physicians and healthcare professionals.
Valuation ConcernsThe stock's premium multiple does not leave any room for error.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $22.96 and its highest was $61.75 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $9.93B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is Feb 06, 2025 which is in 19 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on Nov 07, 2024. The company reported $0.3 earnings per share for the quarter, beating the consensus estimate of $0.255 by $0.045.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Undervalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.34.
How many shares outstanding does Doximity have?
Doximity has 128,135,990 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.3 in its last earnings report, beating expectations of $0.255. Following the earnings report the stock price went up 34.155%.
Which hedge fund is a major shareholder of Doximity?
Among the largest hedge funds holding Doximity’s share is Gotham Asset Management LLC. It holds Doximity’s shares valued at 2M.
---
Doximity Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$58.14 (9.27% Upside)
$58.14 (9.27% Upside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 188.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.54%
12-Months-Change
Fundamentals
Return on Equity
19.00%
Trailing 12-Months
Asset Growth
9.06%
Trailing 12-Months
Company Description
Doximity
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
---
DOCS Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call for Doximity showed robust performance with significant revenue growth, improved EBITDA margins, and strong engagement metrics. The success of new products and the client portal contributed positively, although concerns about Q4 revenue growth and stability in the health system business were noted.Read More>---
DOCS Revenue Breakdown
93.00% Subscription
7.00% Other
---
DOCS Stock 12 Month Forecast
Average Price Target
$58.14
▲(9.27% Upside)
Technical Analysis
Teladoc
―
American Well
―
Hims & Hers Health
―
GoodRx Holdings
―
Pediatrix Medical Group
―
HCA Healthcare
―
Best Analysts Covering DOCS
1 Year
1 Year Success Rate
5/15 ratings generated profit
1 Year Average Return
+5.78%
reiterated a buy rating 2 months ago
Copying Vikram Kesavabhotla's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +5.78% per trade.
---